期刊文献+

持续性肺部感染铜绿假单胞菌的耐药机制

Drug resistant mechanism of Pseudomonas aeruginosaleading to persistent pulmonary infections
原文传递
导出
摘要 目的探讨临床引起持续性肺部感染的铜绿假单胞菌(PAE)耐药机制。方法通过对临床分离的PAE在体外诱导形成生物被膜能力和其在体外的药物敏感性,探讨PAE在临床引起持续性感染的耐药机制。结果在临床引起持续性感染PAE的生物被膜生成能力显著高于非持续性感染的PAE,在临床引起持续性和非持续性感染的PAE在体外药敏试验中均具有比较高的耐药性,虽然二者耐药率差异无统计学意义,但在临床引起持续性感染的PAE对部分抗菌药物的耐药性,如哌拉西林、替卡西林/克拉维酸、头孢他啶、头孢曲松、头孢噻肟、头孢吡肟、氨曲南等有高于引起非持续性感染PAE的趋势。结论 PAE强的生物膜生成能力和其浮游菌比较高的耐药性趋势,是PAE在临床引起持续性感染的重要机制。 OBJECTIVE To study the mechanism leading to the persistent pulmonary infections caused by Pseudomonas aeruginosa.METHODS The mechanism of P.aeruginosa that leads to the persistent pulmonary infections was explored by analyzing the ability of forming biofilm under in vitro induction and the in vitro drug susceptibility testing.RESULTS The ability of forming biofilm by P.aeruginosa causing persistent pulmonary infections was stronger than that causing non-persistent pulmonary infections,the in vitro drug susceptibility testing showed that the drug resistance rate of P.aeruginosa causing persistent infections and non-persistent infections was relatively high,the difference in the drug resistance was not statistically significant,the drug resistance rates of P.aeruginosa causing persistent infections to piperacillin,ticarcillin/clavulanic acid,ceftaczidime,ceftriaxone,cefotaxime,cefepime,and aztreonam were higher than those of P.aeruginosa causing non-persistent infections.CONCLUSION The strong ability of forming biofilm and the high drug resistance of planktonic P.aeruginosa are the important mechanisms that leads to persistent infections caused by P.aeruginosa.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第17期3688-3689,共2页 Chinese Journal of Nosocomiology
关键词 铜绿假单胞菌 生物被膜 耐药性 持续感染 Pseudomonas aeruginosa Biofilm Drug resistance Persistent infection
  • 相关文献

参考文献6

  • 1Moskowitz SM,Foster JM,Emerson JC,et al.Use of Pseud-omonas biofilm susceptibilities to assign simulated antibioticregimens for cystic fibrosis airway infection[J].J AntimicrobChemother,2005,56(9):879-886.
  • 2papavasileiou,K,papavasileiou E,Tseleni-kotsovili A,et al.Comparative antimicrobial susceptibility of biofilm versusplanktonic forms of salmonella enterica strains isolated fromchildren with gastroenteritis european[J].Journal of clinicalmicrobiology/infection Diseases,2010,29(11):1401-1405.
  • 3杨维青,刘晓峰,黄震.铜绿假单胞菌临床菌株生物被膜的定量分析[J].中国抗生素杂志,2009,34(3):181-183. 被引量:18
  • 4Ciornei CD,Novikov A,Beloin C,eta l.Biofilm-forming Pseudo-monas aeruginosa bacteria undergo lipopolysaccharide structuralmodifications and induce enhanced inflammatory cytokine responsein human monocytes[J].Innate immunity,2010,16(5):288-301.
  • 5潘小划,徐艳红,何晓明.铜绿假单胞菌97株产β-内酰胺酶状况的调查[J].河北医学,2009,15(5):534-537. 被引量:2
  • 6Herrmann G,Yang L,Wu H,et al.Colistin-tobramycin com-binations are superior to monotherapy concerning the killingof biofilmPseudomonas aeruginosa[J].Journal of InfectiousDiseases,2010,202(10):1585-1592.

二级参考文献12

  • 1Klausen M,Heydom A,Ragas P, et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants[J]. Mol Microbiol,2003, 48(6): 1511 - 1524.
  • 2Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms[J]. Microbes Infect, 2003, 5(13): 1213 - 1219.
  • 3Stepanovie S, Vukovie D, Dakie I, et al. A modified microtiter-plate test for quantification of Staphylococcal biofilm formation[J]. J Microbiol Methods,2000, 40(2) : 175 - 179.
  • 4Walters M C, Roe F, Bugnicourt A , et al. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity tolerance of Pseudomonas aeruginose biofilm to ciprofloxacin and tobramyein [ J ]. Antimicrob Agents Chemother, 2003,47(1): 317 -323.
  • 5Head N E, Yu H. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: Biofilm formarion, cirulence, and genome diversity[J]. Infect Iramun, 2004, 72( 1 ) : 133 - 144.
  • 6Ciofu O, Fussing V, Bagge N, et al. Characterization of paired mucoid/non-mucoid Pseudomonos aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, β-lactamase activity and RiboPrinting[J]. J Antimicrob Chemother, 2001, 48(3): 391 - 396.
  • 7Moskowitz S M, Foster J M, Emerson J C, et al. Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection[J]. J Antimicrob Chemother, 2005, 56(9) :879 - 886.
  • 8张凤凯 MalcomG PageP 等.PA对β-内酰胺酶类抗生素耐药性决定因素的研究.中国抗生素杂志,2006,25(5):362-367.
  • 9Bush K,Jacoby G A,Medeiros A A.A functional classification scheme for beta-lactamases and its correlation with molecular structure[J].Antimicrob Agents Chemother,2007,39(6):1211-1214.
  • 10徐英春 陈民均.AmpC酶与革兰氏阴性菌的耐药特征.中华微生物学和免疫学杂志,2008,21:14-16.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部